A2A-252

N/A

Report date: 2026/04/15 20:02:38
NME

Base Information

Drug NameA2A-252
Drug Alias NameA2A-252A-2-A-252AO-252
ClassificationSmall molecules
Mechanisms of ActionTransforming acidic coiled-coil-containing protein 3 inhibitorsProtein-protein interaction inhibitors
TargetsTransforming acidic coiled-coil-containing protein 3Protein-protein interaction
Therapy Area/IndicationsSolid tumoursNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesA2A Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesRoquefort Therapeutics plcA2A Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm Metastasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A